Silence Therapeutics's total assets for Q1 2025 were £185.30M, a decrease of -8.56% from the previous quarter. SLN total liabilities were £72.56M for the fiscal quarter, a 5.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.